Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Fries
E. Fries
Utrecht University
Immunology
Diabetes mellitus
Medicine
Oncology
Internal medicine
4
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT
2013
Bone Marrow Transplantation
P.J. de Pagter
R. Schuurman
L. Keukens
Martin Schutten
J. Cornelissen
D. van Baarle
E. Fries
Elisabeth A. M. Sanders
M. C. Minnema
B R van der Holt
Ellen Meijer
J.J. Boelens
Show All
Source
Cite
Save
Citations (24)
HHV6 reactivation is an important risk factor for poor outcomes in myeloablative, but not in non-myeloablative treated allogeneic HSCT patients
2009
Bone Marrow Transplantation
A.P.J. de Pagter
Ellen Meijer
L. Keukens
Martin Schutten
Jan J. Cornelissen
D. van Baarle
E. Fries
R. Schuurman
Elisabeth A. M. Sanders
J.J. Boelens
Show All
Source
Cite
Save
Citations (0)
HHV6 Reactivation is an Important Riskfactor for Poor Outcomes in Myeloablative, But Not in Non-Myeloablative Treated Allogeneic HSCT Patients
2009
Biology of Blood and Marrow Transplantation
A.P.J. Pagter
Ellen Meijer
L. Keukens
Martin Schutten
Jan J. Cornelissen
Debbie van Baarle
E. Fries
Rob Schuurman
J.J. Boelens
Show All
Source
Cite
Save
Citations (0)
HHV6 reactivation : important risk-factor for poor outcome in myeloablative treated stem cell transplantation adult recipients
2008
Bone Marrow Transplantation
A.P.J. de Pagter
Ellen Meijer
D. van Baarle
E. Fries
Lf Verdonck
A.M. van Loon
R. Schuurman
J.J. Boelens
Show All
Source
Cite
Save
Citations (1)
1